The hepatitis C virus (HCV) infects 71.1 million persons and causes 400,000 deaths
annually worldwide. HCV mostly infects the liver, causing acute and chronic …

Cirrhosis is the most important risk factor for hepatocellular carcinoma (HCC) regardless of
the etiology of cirrhosis. Compared to individuals who are anti-hepatitis C virus (HCV) …

Chronic infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease
and its complications, including cirrhosis, decompensated cirrhosis, hepatocellular …

Liver disease is the major complication of chronic HCV infection. However, extrahepatic
complications are common (50–75%), including mixed cryoglobulinaemia and B-cell …

ABSTRACT Introduction Hepatitis C virus (HCV) causes a systemic infection inducing
hepatic and extrahepatic diseases. These latter involve cardiovascular system, kidney …

ABSTRACT Introduction: Hepatitis C virus (HCV) represents a major health concern, as
nearly 3 million people become newly infected by this pathogen annually. The majority of …

It has long been recognized that when a sustained virological response (SVR) occurs after
antiviral treatment for chronic hepatitis C virus (HCV), there is a reduced risk of cirrhosis …

The public health impact of hepatitis C virus (HCV) infection has been realized only recently.
Globally, 71 million people are living with HCV chronic infection. HCV prevalence is higher …

To examine mid‐term benefits on hepatic complications, extrahepatic clinical syndromes
and quality of life associated with HCV cure; to review the few safety issues linked to oral …

Approximately 350 million people worldwide are infected with hepatitis C virus (HCV), which
is associated with morbidity and mortality related to cirrhosis, hepatocellular carcinoma, or …